7-bromo-6-chloro-3,4-dihydro-2H-isoquinolin-1-one;2-bromo-6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridine;carbanide;6-chloro-7-(4-cyclopropylimidazol-1-yl)-3,4-dihydro-2H-isoquinolin-1-one;6-chloro-7-(4-cyclopropylimidazol-1-yl)-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]-3,4-dihydroisoquinolin-1-one;5-cyclopropyl-1H-imidazole;tungsten
C66H67Br2Cl3N17O3W- — CID 159837695
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-bromo-6-chloro-3,4-dihydro-2H-isoquinolin-1-one;2-bromo-6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridine;carbanide;6-chloro-7-(4-cyclopropylimidazol-1-yl)-3,4-dihydro-2H-isoquinolin-1-one;6-chloro-7-(4-cyclopropylimidazol-1-yl)-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]-3,4-dihydroisoquinolin-1-one;5-cyclopropyl-1H-imidazole;tungsten
7-bromo-6-chloro-3,4-dihydro-2H-isoquinolin-1-one;2-bromo-6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridine;carbanide;6-chloro-7-(4-cyclopropylimidazol-1-yl)-3,4-dihydro-2H-isoquinolin-1-one;6-chloro-7-(4-cyclopropylimidazol-1-yl)-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]-3,4-dihydroisoquinolin-1-one;5-cyclopropyl-1H-imidazole;tungsten (PubChem CID 159837695) has the molecular formula C66H67Br2Cl3N17O3W- and a molecular weight of 1596.38 g/mol. Its IUPAC name is 7-bromo-6-chloro-3,4-dihydro-2H-isoquinolin-1-one;2-bromo-6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridine;carbanide;6-chloro-7-(4-cyclopropylimidazol-1-yl)-3,4-dihydro-2H-isoquinolin-1-one;6-chloro-7-(4-cyclopropylimidazol-1-yl)-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]-3,4-dihydroisoquinolin-1-one;5-cyclopropyl-1H-imidazole;tungsten.
Molecular Properties
| Compound Name | 7-bromo-6-chloro-3,4-dihydro-2H-isoquinolin-1-one;2-bromo-6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridine;carbanide;6-chloro-7-(4-cyclopropylimidazol-1-yl)-3,4-dihydro-2H-isoquinolin-1-one;6-chloro-7-(4-cyclopropylimidazol-1-yl)-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]-3,4-dihydroisoquinolin-1-one;5-cyclopropyl-1H-imidazole;tungsten |
|---|---|
| PubChem CID | 159837695 |
| Molecular Formula | C66H67Br2Cl3N17O3W- |
| Molecular Weight | 1596.38 g/mol |
| Exact Mass | 1592.26 |
| IUPAC Name | 7-bromo-6-chloro-3,4-dihydro-2H-isoquinolin-1-one;2-bromo-6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridine;carbanide;6-chloro-7-(4-cyclopropylimidazol-1-yl)-3,4-dihydro-2H-isoquinolin-1-one;6-chloro-7-(4-cyclopropylimidazol-1-yl)-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]-3,4-dihydroisoquinolin-1-one;5-cyclopropyl-1H-imidazole;tungsten |
| SMILES | CC(C)n1cnnc1-c1cccc(Br)n1.CC(C)n1cnnc1-c1cccc(N2CCc3cc(Cl)c(-n4cnc(C5CC5)c4)cc3C2=O)n1.O=C1NCCc2cc(Cl)c(-n3cnc(C4CC4)c3)cc21.O=C1NCCc2cc(Cl)c(Br)cc21.[CH3-].[W].c1ncc(C2CC2)[nH]1 |
| InChI | InChI=1S/C25H24ClN7O.C15H14ClN3O.C10H11BrN4.C9H7BrClNO.C6H8N2.CH3.W/c1-15(2)33-14-28-30-24(33)20-4-3-5-23(29-20)32-9-8-17-10-19(26)22(11-18(17)25(32)34)31-12-21(27-13-31)16-6-7-16;16-12-5-10-3-4-17-15(20)11(10)6-14(12)19-7-13(18-8-19)9-1-2-9;1-7(2)15-6-12-14-10(15)8-4-3-5-9(11)13-8;10-7-4-6-5(3-8(7)11)1-2-12-9(6)13;1-2-5(1)6-3-7-4-8-6;;/h3-5,10-16H,6-9H2,1-2H3;5-9H,1-4H2,(H,17,20);3-7H,1-2H3;3-4H,1-2H2,(H,12,13);3-5H,1-2H2,(H,7,8);1H3;/q;;;;;-1; |
| InChIKey | DRIHJCZJSKPWNY-UHFFFAOYSA-N |
| XLogP | 14.34 |
| TPSA | 230.03 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 92 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1596.38 |
| LogP ≤ 5 | 14.34 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159837695 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.